Christopher J Goodenough1, Kathryn T Anderson2, Kari E Smith3, Robert A Hanfland4, Nitin Wadhwa5, John F Teichgraeber3, Matthew R Greives3. 1. 1 Department of General Surgery, McGovern School of Medicine, The University of Texas Health Science Center at Houston and Children's Memorial Hermann Hospital, Houston, TX, USA. 2. 2 Department of Pediatric Surgery, McGovern School of Medicine, The University of Texas Health Science Center at Houston and Children's Memorial Hermann Hospital, Houston, TX, USA. 3. 3 Division of Pediatric Plastic Surgery, Department of Pediatric Surgery, McGovern School of Medicine, The University of Texas Health Science Center at Houston and Children's Memorial Hermann Hospital, Houston, TX, USA. 4. 4 Division of Pediatric Cardiac Surgery, Department of Pediatric Surgery, McGovern School of Medicine, The University of Texas Health Science Center at Houston and Children's Memorial Hermann Hospital, Houston, TX, USA. 5. 5 Division of Pediatric Anesthesia, Department of Anesthesia, McGovern School of Medicine, The University of Texas Health Science Center at Houston and Children's Memorial Hermann Hospital, Houston, TX, USA.
Abstract
OBJECTIVE: To assess the risk of complication in patients undergoing cleft palate repair with congenital cardiac comorbidities in a large, national cohort. DESIGN: Retrospective review. PATIENTS/ SETTING: Using the 2012-2014 National Surgical Quality Improvement Program (NSQIP) Pediatric database, patients undergoing cleft palate repair were selected for analysis. Patients with cleft palate repairs were stratified based on the presence or absence congenital cardiac comorbidities. Univariate and stepwise forward logistic regression were conducted. MAIN OUTCOME MEASURES: It is hypothesized that risk of postoperative adverse events in patients with congenital cardiac comorbidities is higher than in patients without cardiac disease. RESULTS: Nationally, between 2012 and 2014, 3240 patients underwent cleft palate repair, 422 (13.0%) with cardiac disease, and 2818 (87.0%) without cardiac disease. Patients with cardiac disease were smaller (10.5 [6.6] kg vs 11.6 [8.6] kg, P < .01) and more likely to be premature (4.6% vs 13.0%, P < .01) compared to those without cardiac disease. Postoperatively, patients with cardiac conditions were more likely to experience an adverse event (8.8% vs 4.2%, P < .01). Specifically, they were more likely to experience reintubation (1.7% vs 0.4%, P < .01), reoperation (2.1% vs 0.6%, P < .01), and longer length of stay (2.7 [7.0] vs 1.6 [2.8] days, P < .01). Rates of surgical site infection and dehiscence were not different. CONCLUSIONS: Cleft palate repair in patients with concurrent congenital cardiac defects is a safe procedure but carries elevated risk in the postoperative period as demonstrated in this analysis of the NSQIP-Pediatric database. Technical risks are equivalent. Additional anesthesia and surgical awareness of these potential complications is essential to minimize perianesthesia risks.
OBJECTIVE: To assess the risk of complication in patients undergoing cleft palate repair with congenital cardiac comorbidities in a large, national cohort. DESIGN: Retrospective review. PATIENTS/ SETTING: Using the 2012-2014 National Surgical Quality Improvement Program (NSQIP) Pediatric database, patients undergoing cleft palate repair were selected for analysis. Patients with cleft palate repairs were stratified based on the presence or absence congenital cardiac comorbidities. Univariate and stepwise forward logistic regression were conducted. MAIN OUTCOME MEASURES: It is hypothesized that risk of postoperative adverse events in patients with congenital cardiac comorbidities is higher than in patients without cardiac disease. RESULTS: Nationally, between 2012 and 2014, 3240 patients underwent cleft palate repair, 422 (13.0%) with cardiac disease, and 2818 (87.0%) without cardiac disease. Patients with cardiac disease were smaller (10.5 [6.6] kg vs 11.6 [8.6] kg, P < .01) and more likely to be premature (4.6% vs 13.0%, P < .01) compared to those without cardiac disease. Postoperatively, patients with cardiac conditions were more likely to experience an adverse event (8.8% vs 4.2%, P < .01). Specifically, they were more likely to experience reintubation (1.7% vs 0.4%, P < .01), reoperation (2.1% vs 0.6%, P < .01), and longer length of stay (2.7 [7.0] vs 1.6 [2.8] days, P < .01). Rates of surgical site infection and dehiscence were not different. CONCLUSIONS:Cleft palate repair in patients with concurrent congenital cardiac defects is a safe procedure but carries elevated risk in the postoperative period as demonstrated in this analysis of the NSQIP-Pediatric database. Technical risks are equivalent. Additional anesthesia and surgical awareness of these potential complications is essential to minimize perianesthesia risks.
Entities:
Keywords:
hard palate; palatoplasty; soft palate; surgical complications
Authors: Marisa Bartz-Kurycki; Shuyan Wei; Karla Bernardi; Joseph K Moffitt; Matthew R Greives Journal: J Craniofac Surg Date: 2019 Mar/Apr Impact factor: 1.046
Authors: Christopher J Goodenough; Cassie A Hartline; Shuyan Wei; Joseph K Moffitt; Alfredo Cepeda; Phuong D Nguyen; Matthew R Greives Journal: Eplasty Date: 2022-09-07